TITLE

Treatment of Menorrhagia with Tranexamic Acid. A Double-blind Trial

AUTHOR(S)
Callender, Shei La T.; Warner, G. T.; Cope, E.
PUB. DATE
October 1970
SOURCE
British Medical Journal;10/24/1970, Vol. 4 Issue 5729, p214
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64098295

 

Related Articles

  • Effectiveness of medical management of menorrhagia. Walling, Anne D. // American Family Physician;12/1/1996, Vol. 54 Issue 8, p2533 

    Presents a summary of the article `Treatment of Menorrhagia During Menstruation: Randomised Controlled Trial of Ethamsylate, Mefenamic Acid, and Tranexamic Acid,' by J. Bonnard and B.L. Sheppard from the `British Medical Journal' dated 1996. Method used in the study; Pathophysiology of...

  • Treatment of menorrhagia during menstruation: Randomized controlled trial of ethamsylate... Bonnar, John; Sheppard, Brian L. // BMJ: British Medical Journal (International Edition);9/7/96, Vol. 313 Issue 7057, p579 

    Presents a randomized controlled trial comparing the efficacy and acceptability of ethamsylate, mefenamic acid and tranexamic acid for treating menorrhagia. Reduction of blood loss by mefenamic and tranexamic acid; Efficacy of tranexamic acid for treating excessive bleeding; Option of patients...

  • TREATMENT OPTIONS FOR MENORRHAGIA. Jarvis, Sarah // Practice Nurse;11/28/2003, Vol. 26 Issue 9, p60 

    Discusses menorrhagia and various treatment options for the condition. Pathology associated with objective menorrhagia; Factors consider in the assessment of the condition; Effectiveness of non steroidal anti-inflammatory drugs on reducing menstrual blood flow; Health risk posed by tranexamic...

  • Mefenamic acid/tranexamic acid.  // Reactions Weekly;8/1/2013, Issue 1463, p24 

    The article presents a case study of a 41-year-old woman diagnosed with acute myocardial infarction while administering mefenamic acid/tranexamic acid for dysmenorrhoea and menorrhagia treatment.

  • Tranexamic Acid. Wellington, Keri; Wagstaff, Antona J. // Drugs;2003, Vol. 63 Issue 13, p1417 

    Examines the efficacy of tranexamic acid in the management of menorrhagia. Mechanism behind its antifibrinolytic effect; Pharmacodynamic and pharmacokinetic properties; Advantage of tranexamic acid over other drugs.

  • HALT-IT - tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. Roberts, Ian; Coats, Timothy; Edwards, Phil; Gilmore, Ian; Jairath, Vipul; Ker, Katharine; Manno, Daniela; Shakur, Haleema; Stanworth, Simon; Veitch, Andrew // Trials;2014, Vol. 15 Issue 1, p2 

    Background Gastrointestinal bleeding is a common emergency that causes substantial mortality worldwide. Acute upper and lower gastrointestinal bleeding accounts for about 75,000 hospital admissions each year in the UK and causes the death of about 10% of these patients. Tranexamic acid has been...

  • Improvements observed in menorrhagia disorders. James, Andra // Hem/Onc Today;2/10/2008, Vol. 9 Issue 2, p22 

    The article discusses a study of the use of intranasal desmopressin and oral tranexamic acid in menorrhagia disorders, which was presented at the 49th American Society of Hematology Annual Meeting and Exposition in Atlanta, Georgia. Findings showed that both treatments reduced menstrual blood...

  • Tranexamic acid is an effective oral treatment for women with heavy menstrual bleeding.  // Drugs & Therapy Perspectives;May2004, Vol. 20 Issue 5, p1 

    Tranexamic acid, a synthetic lysine derivative with antifibrinolytic activity, is used to control blood loss in a variety of surgical settings and bleeding disorders, including heavy menstrual bleeding (menorrhagia). In clinical trials in women with heavy menstrual bleeding, oral tranexamic acid...

  • New Medical Treatment of Heavy Menstrual Bleeding. Ling, Frank W. // OB/GYN Clinical Alert;Apr2011, Vol. 27 Issue 12, p89 

    In a double-blind, randomized, placebo-controlled trial, oral tranexamic acid was well-tolerated and improved quality of life and menstrual blood flow in patients with heavy menstrual bleeding.

  • Reducing Heavy Menstrual Bleeding: Safety and Efficacy of Tranexamic Acid. Perriera, Lisa; Martin, Janet; Ahuja, Sanjay P. // Clinical Medicine Insights: Women's Health;2012, Issue 5, p17 

    Menorrhagia or Heavy Menstrual Bleeding (HMB) remains a public health challenge among women in the reproductive age group. Anti-fibrinolytics such as tranexamic acid and epsilon aminocaproic acid, play an important role in the medical management of HMB, as HMB is associated with an increase in...

Share

Read the Article

Other Topics